Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Incompetence arrives on The Most Inopportune Day

<< Previous

Bullboard Posts

Next >>

Comment by rixpixon Jan 07, 2022 6:01pm

414 Views

Post# 34294914

RE:RE:Incompetence arrives on The Most Inopportune Day

I agree with you, Merc. Nothing wrong with taking a bit off the table here. No one ever went broke selling at a profit.

Also agree with BioTeck that it's not the articles and price targets that'll dictate what price SVA will be.
WIthout great results or any deals coming soon, price targets won't matter.

Agree with Red Barron too. The analyst's price target will, no doubt, change with new results.
It was an old report based on last year's results so we shouldn't worry about it now.

All in all a good week. See you all again Monday.
CHeers!!!

<< Previous

Bullboard Posts

Next >>

This AI stock is disrupting the event tickets monopoly